Posts
-
New Inhibitor Improves Autism-Like Symptoms in Mice
A Northwestern University experimental therapeutic targeting a specific protein kinase reversed neurological symptoms in a mouse genetic model of autism, according to a recent Northwestern Medicine study.
-
New Therapeutic Target for Metabolic Disorders
Scientists have identified a novel regulator of liver metabolism, which could serve as a potential therapeutic target for obesity, type 2 diabetes and related conditions.
-
Mechanisms of Mitochondrial Dysfunction in ALS
Northwestern Medicine scientists have demonstrated that mitochondrial damage plays a critical early role in a group of diseases, including forms of ALS and dementia.